CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis

Abdullah A. Tarique, Peter D. Sly, Patrick G. Holt, Anthony Bosco, Robert S. Ware, Jayden Logan, Scott C. Bell, Claire E. Wainwright, Emmanuelle Fantino

Research output: Contribution to journalArticlepeer-review

40 Citations (Web of Science)


Background The role of the macrophages in cystic fibrosis (CF) lung disease has been poorly studied. We hypothesized that alternatively activated M2 macrophages are abnormal in CF lung disease. Methods Blood samples were collected from adults (n = 13) children (n = 27) with CF on admission for acute pulmonary exacerbation and when clinically stable. Monocytes were differentiated into macrophages and polarized into classical (M1) and alternatively-activated (M2) phenotypes, function determined ex-vivo and compared with healthy controls. Results In the absence of functional cystic fibrosis trans-membrane conductance regulator (CFTR), either naturally in patients with CF or induced with CFTR inhibitors, monocyte-derived macrophages do not respond to IL-13/IL-4, fail to polarize into M2s associated with a post-transcriptional failure to produce and express IL-13Rα1 on the macrophage surface Polarization to the M1 phenotype was unaffected. Conclusions CFTR-dependent imbalance of macrophage phenotypes and functions could contribute to the exaggerated inflammatory response seen in CF lung disease.

Original languageEnglish
Pages (from-to)475-482
Number of pages8
JournalJournal of Cystic Fibrosis
Issue number4
Publication statusPublished - 1 Jul 2017


Dive into the research topics of 'CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis'. Together they form a unique fingerprint.

Cite this